Participating in Clinical Research Studies

EMBOLD is a clinical research study, which means it’s being conducted to test the safety and effectiveness of an investigational treatment. Clinical research studies evaluate safety and effectiveness before treatments are made available to the general public. Studies are monitored by institutional review boards and/or ethics committees, and patient safety is the top priority.

These groups make sure that:

The rights of participants are protected
All known risks are outlined for participants
The study addresses important unanswered medical questions

If you decide to pursue participation in the study and initially qualify, you will be directed to a study center and speak with the study team. You will receive an Informed Consent Form (ICF), which tells you about the research study and explains the tests and procedures involved. Knowing what is involved will help you decide if you want to take part in the research.

Participation in this research is voluntary. If you don’t wish to take part, you don’t have to. You may stop the investigational treatment or withdraw your consent at any time without affecting your medical care.

Participating During COVID-19

As you consider taking part in the EMBOLD Study, please know that our highest priority is protecting your health and well-being during the COVID-19 pandemic. Our study doctors and nurses follow safety guidelines and are taking all reasonable precautions to help ensure study participants feel safe attending every study visit.

If you choose to speak with a study doctor about taking part in the study, they can provide detailed information about how they keep patients safe during study visits.